Boenisch Sandra's most recent trade in Anavex Life Sciences Corporation was a trade of 12,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 15, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Anavex Life Sciences Corpo... | Sandra Boenisch | PFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | Boenisch Sandra | PFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | Sandra Boenisch | PFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2024 | 10,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | Sandra Boenisch | PFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | Sandra Boenisch | PFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | Sandra Boenisch | PFO and Treasurer | Sale of securities on an exchange or to another person at price $ 26.53 per share. | 29 Jun 2021 | 166,696 | 22,963 (0%) | 0% | 26.5 | 4,422,445 | Common Stock |
Anavex Life Sciences Corpo... | Sandra Boenisch | PFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.28 per share. | 29 Jun 2021 | 106,696 | 154,659 (0%) | 0% | 3.3 | 349,963 | Common Stock |
Anavex Life Sciences Corpo... | Sandra Boenisch | PFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2021 | 106,696 | 0 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | Sandra Boenisch | PFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2021 | 35,000 | 0 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | Sandra Boenisch | PFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.92 per share. | 29 Jun 2021 | 35,000 | 189,659 (0%) | 0% | 5.9 | 207,200 | Common Stock |
Anavex Life Sciences Corpo... | Sandra Boenisch | PFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2021 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
Anavex Life Sciences Corpo... | Sandra Boenisch | PFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.68 per share. | 29 Jun 2021 | 25,000 | 47,963 (0%) | 0% | 5.7 | 142,000 | Common Stock |